Kenneth Stauderman
Fondatore presso CALCIMEDICA, INC.
Patrimonio netto: 67 842 $ in data 31/05/2024
Posizioni attive di Kenneth Stauderman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CALCIMEDICA, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2007 | - |
| Fondatore | 01/04/2007 | - | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Direttore Tecnico/Scientifico/R&S | 01/12/2006 | - |
| Fondatore | 11/08/2009 | - |
Storia della carriera di Kenneth Stauderman
Precedenti posizioni note di Kenneth Stauderman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01/01/2000 | 01/01/2007 |
| Sibia Neurosciences, Inc. | Corporate Officer/Principal | 01/01/1994 | 01/01/2000 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/1986 | 01/01/1994 |
| Marion Merrell Dow Pharmaceutical, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Kenneth Stauderman
| University of Virginia | Undergraduate Degree |
| Texas University of Health Center at San Antonio | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Canada | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CALCIMEDICA, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
| Sibia Neurosciences, Inc. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
| Marion Merrell Dow Pharmaceutical, Inc. |
- Borsa valori
- Insiders
- Kenneth Stauderman
- Esperienza
